1. Home
  2. UFG vs SER Comparison

UFG vs SER Comparison

Compare UFG & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uni-Fuels Holdings Limited

UFG

Uni-Fuels Holdings Limited

HOLD

Current Price

$0.45

Market Cap

27.6M

Sector

Energy

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.37

Market Cap

30.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFG
SER
Founded
2021
2017
Country
Singapore
United States
Employees
26
16
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.6M
30.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UFG
SER
Price
$0.45
$2.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
59.7K
31.0K
Earning Date
04-22-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$211.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$1.22
52 Week High
$9.91
$7.92

Technical Indicators

Market Signals
Indicator
UFG
SER
Relative Strength Index (RSI) 19.87 65.16
Support Level N/A $1.74
Resistance Level $1.02 $3.25
Average True Range (ATR) 0.05 0.15
MACD -0.02 0.01
Stochastic Oscillator 2.77 90.24

Price Performance

Historical Comparison
UFG
SER

About UFG Uni-Fuels Holdings Limited

Uni-Fuels Holdings Ltd is a service provider of marine fuel solutions. It operates on an integrated business model, serving customers through two operating models: sales of marine fuels solutions and brokerage (i.e., acting as an intermediary between marine fuels suppliers and customers for a commission). The various marine fuel products offered by the company include very low sulfur fuel oil, high sulfur fuel oil, marine gas oil, and bio marine fuel. Its customers are mainly shipping companies and other fuel suppliers operating in market sectors such as bulk, tanker, offshore, container, general cargo, tug and barge, car carrier, cruise, yacht, and dredging. Geographically, the company derives maximum revenue from Singapore, and the rest from Malaysia, Hong Kong, China, and other regions.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: